Sec Form 4 Filing - HAQUE PROMOD @ Health Catalyst, Inc. - 2019-07-29

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person HAQUE PROMOD 2. Issuer Name and Ticker or Trading Symbol Health Catalyst, Inc. [ HCAT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 525 UNIVERSITY AVENUE, SUITE 800 3. Date of Earliest Transaction (MM/DD/YY) 07/29/2019 (Street) PALO ALTO, CA94301 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 07/29/2019 C 2,952,091 A 2,952,091 I By Limited Partnership ( 6 ) Common Stock 07/29/2019 C 2,952,090 A 2,952,090 I By Limited Partnership ( 7 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series B Convertible Preferred Stock ( 1 ) 07/29/2019 C 1,442,727 ( 1 ) ( 1 ) Common Stock 1,442,727 $ 0 0 I By Limited Partnership ( 6 ) Series C Convertible Preferred Stock ( 2 ) 07/29/2019 C 577,045 ( 2 ) ( 2 ) Common Stock 577,045 $ 0 0 I By Limited Partnership ( 6 ) Series D Convertible Preferred Stock ( 3 ) 07/29/2019 C 471,832 ( 3 ) ( 3 ) Common Stock 471,832 $ 0 0 I By Limited Partnership ( 6 ) Series E Convertible Preferred Stock ( 4 ) 07/29/2019 C 424,568 ( 4 ) ( 4 ) Common Stock 424,568 $ 0 0 I By Limited Partnership ( 6 ) Series F Convertible Preferred Stock ( 5 ) 07/29/2019 C 35,919 ( 5 ) ( 5 ) Common Stock 35,919 $ 0 0 I By Limited Partnership ( 6 ) Series B Convertible Preferred Stock ( 1 ) 07/29/2019 C 1,442,727 ( 1 ) ( 1 ) Common Stock 1,442,727 $ 0 0 I By Limited Partnership ( 7 ) Series C Convertible Preferred Stock ( 2 ) 07/29/2019 C 577,045 ( 2 ) ( 2 ) Common Stock 577,045 $ 0 0 I By Limited Partnership ( 7 ) Series D Convertible Preferred Stock ( 3 ) 07/29/2019 C 471,831 ( 3 ) ( 3 ) Common Stock 471,831 $ 0 0 I By Limited Partnership ( 7 ) Series E Convertible Preferred Stock ( 4 ) 07/29/2019 C 424,568 ( 4 ) ( 4 ) Common Stock 424,568 $ 0 0 I By Limited Partnership ( 7 ) Series F Convertible Preferred Stock ( 5 ) 07/29/2019 C 35,919 ( 5 ) ( 5 ) Common Stock 35,919 $ 0 0 I By Limited Partnership ( 7 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other HAQUE PROMOD 525 UNIVERSITY AVENUE SUITE 800 PALO ALTO, CA94301 X X Signatures /s/ Matthew De Dominicis, as Attorney-in-fact 07/29/2019 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. ( 2 )The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. ( 3 )The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. ( 4 )The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. ( 5 )The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date. ( 6 )The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP ("NVP XI"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XI, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein. ( 7 )The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP ("NVP XII"). By virtue of his position as a Co-Chief Executive Officer of NVP Associates, LLC ("NVP Associates"), the managing member of the general partner of NVP XII, Promod Haque may be deemed to share voting and dispositive power with respect to such securities. Mr. Haque disclaims beneficial ownership of all such securities, except to the extent of any pecuniary interests therein.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.